Prenatal multivitamins.

Senator Weber Pierson's prenatal multivitamin legislation establishes new testing and disclosure requirements for manufacturers and brand owners selling these supplements in California. The measure requires testing of each production lot for toxic elements including arsenic, cadmium, lead, and mercury at laboratories meeting international accreditation standards.

Starting January 2027, brand owners must publish testing results on their websites, maintaining this information throughout each product's shelf life plus one month. The disclosure requirements include listing toxic element levels by lot number, providing supplement facts panel information, and displaying a standardized statement about varying toxic element levels in prenatal vitamins. Product packaging must direct consumers to where they can access the testing data online.

The legislation creates a comprehensive regulatory framework by defining key terms like "bulk prenatal multivitamin product," establishing laboratory proficiency criteria, and outlining specific responsibilities for both manufacturers and brand owners. Manufacturers must provide test results to state health department officials upon request, while brand owners not directly manufacturing products can comply by sharing their manufacturer's testing data. The measure prohibits the sale or distribution of any prenatal multivitamins that do not meet these requirements.